M-Learning: or mobile learning is "learning across multiple contexts, through social and content interactions, using personal electronic devices". A form of distance education, m-learners use mobile device educational technology at their time convenience.
-
Date: May 13, 2021 Time: 11:00am PST Dr. Dattwyler will share his extensive experience on the clinical diagnosis and treatment of Lyme disease including a brief history of Lyme Disease and h...
Date: April 28, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Learn how the leading food, juice and beverage producer in Mexico, Jugos del Valle, simplified and sped up their lab work and improved...
Learning Objectives: 1. Identify different kinds of genomic resources 2. Learn to apply the features available in genomic resources to cancer variant interpretation 3. Describe the importanc...
The SARS-CoV-2 pandemic is challenging our health care systems and has profoundly impacted our society. Due to the poor global public health response, SARS-CoV-2 has developed many variants....
Traumatic brain injury (TBI) is best characterized as brain dysfunction caused by an outside force, usually a violent blow to the head, often occurring as a result of a severe sports injury...
Date: April 15, 2021 Time: 7:00am (PDT), 10:00am (EDT) In widefield fluorescence microscopy both the contrast and resolution of a captured image is corrupted by light collected from adjacent...
This presentation will focus on strategies for the design and validation of robust assays for the detection of SARS-CoV-2, including nucleic acid extraction, multiplexed qPCR assays, and int...
Register now to receive more information!...
Date: March 30, 2021 Time: 7:00am (PDT), 10:00am (EDT) n this talk today we will discuss how to improve the resolution of your current CE-SDS methods. We will cover how CE-SDS works and what...
Date: March 24, 2021 Time: 7:00am (PST), 10:00am (EST), 3:00pm (CET) Multiplex immunofluorescence IHC is a powerful technique to address the increasing research needs in immuno-oncology t...
G protein-coupled receptors (GPCRs) are among the most intensively studied drug targets, and account for about ~34% of all drugs approved by the FDA. Examples of drugs targeting GPCRs includ...